$マウンテン・クレスト・アクイジション (MCAG.US)$ CUBEBIO Announces Business Combination Agreement With Mountain Crest V to Become Publicly Listed CUBEBIO, a Korean company with innovative early-stage cancer diagnosis technology using urine, has entered into a business combination agreement with Mountain Crest Acquisition Corp. V (MCAG). The deal aims to make CUBEBIO a publicly listed company on Nasdaq. Key details include: 1. Pre-transaction equity value for CUBEBIO: $375 million ...
マウンテン・クレスト・アクイジションに関するコメント
CUBEBIO Announces Business Combination Agreement With Mountain Crest V to Become Publicly Listed
CUBEBIO, a Korean company with innovative early-stage cancer diagnosis technology using urine, has entered into a business combination agreement with Mountain Crest Acquisition Corp. V (MCAG). The deal aims to make CUBEBIO a publicly listed company on Nasdaq. Key details include:
1. Pre-transaction equity value for CUBEBIO: $375 million
...
まだコメントはありません